Pharma Aids Limited (DSE:PHARMAID)
Bangladesh · Delayed Price · Currency is BDT 505.60
-7.20 (-1.40%)
At close: Nov 12, 2026
Pharma Aids Financials Overview
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 507.39 | 507.39 | 438.09 | 421.23 | 308.49 | 323.05 |
Revenue Growth | 15.82% | 15.82% | 4.00% | 36.55% | -4.50% | 15.25% |
Gross Profit Gross Profit Growth | 161.93 | 161.93 | 131.99 | 129.36 | 51.29 | 103.47 |
Operating Income Operating Income Growth | 111.27 | 111.27 | 83.41 | 84.36 | 10.66 | 54.02 |
Net Income Net Income Growth | 87.52 | 87.52 | 63.82 | 61.19 | -6.38 | 34.76 |
Earnings Per Share EPS Growth | 28.05 | 28.05 | 20.45 | 19.61 | -2.05 | 11.14 |
EPS Growth | 37.16% | 37.14% | 4.30% | - | - | -30.83% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 57.78 | 57.78 | 11.2 | 32.72 | 15.12 | 24.91 |
Total Debt Total Debt Growth | 14.33 | 14.33 | 27.3 | 18.16 | 11.47 | 0.99 |
Net Cash (Debt) Net Cash Growth | 43.45 | 43.45 | -16.1 | 14.56 | 3.64 | 23.92 |
Net Cash Growth | - | - | - | 299.66% | -84.77% | 21.59% |
Net Cash Per Share Net Cash Per Share Growth | 13.93 | 13.93 | -5.16 | 4.67 | 1.17 | 7.67 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 76.64 | 76.64 | 39.76 | 22.79 | 7.27 | 33.85 |
Capital Expenditures CapEx Growth | -20.44 | -20.44 | -57.13 | -0.18 | -2.21 | -4.7 |
Free Cash Flow Free Cash Flow Growth | 56.2 | 56.2 | -17.37 | 22.6 | 5.06 | 29.15 |
Free Cash Flow Growth | - | - | - | 346.82% | -82.64% | 37.97% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 31.91% | 31.91% | 30.13% | 30.71% | 16.63% | 32.03% |
Operating Margin | 21.93% | 21.93% | 19.04% | 20.03% | 3.46% | 16.72% |
Pretax Margin | 21.52% | 21.52% | 18.79% | 20.08% | 3.34% | 16.57% |
Profit Margin | 17.25% | 17.25% | 14.57% | 14.53% | -2.07% | 10.76% |
FCF Margin | 11.08% | 11.08% | -3.97% | 5.37% | 1.64% | 9.02% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Dividend Per Share Dividend Per Share Growth | 3.000 | - | 3.000 | 2.500 | 1.000 | 5.000 |
Dividend Per Share Growth | 16.67% | - | 20.00% | 150.00% | -80.00% | 0% |
Dividend Yield | 0.59% | - | 0.56% | 0.37% | 0.13% | 0.61% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 18.02 | 21.29 | 26.18 | 34.09 | - | 73.14 |
P/FCF Ratio | 28.07 | 33.16 | - | 92.27 | 487.65 | 87.25 |
PS Ratio | 3.11 | 3.67 | 3.81 | 4.95 | 8.00 | 7.87 |